Key result
A Delphi process identified substantial agreement on the need for a targeted screening pathway using combined imaging and genetic testing for adult relatives of patients with thoracic aortic disease.
Why the study?
A consensus exercise was needed to determine the acceptability of screening, test sequences, long-term management, and trial design to inform a clinical trial of targeted screening for relatives of individuals with thoracic aortic disease.
A patient-initiated Delphi process identified key areas of consensus and ongoing uncertainty regarding the design of a targeted screening programme for thoracic aortic disease.
Answers are grounded in this paper and cite their sources.
Supports targeted screening consensus for thoracic aortic disease relatives; leaves open optimal pathway design and cost-effectiveness.
OBJECTIVES: To inform the design of a clinical trial of a targeted screening programme for relatives of individuals affected by thoracic aortic disease, we performed a consensus exercise as to the acceptability of screening, the optimal sequence and choice of tests, long-term patient management, and choice of trial design. METHODS: Working with the Aortic Dissection Awareness UK & Ireland patient association, we performed a Delphi exercise with clinical experts, patients, and carers, consisting of three rounds of consultation followed by a final multi-stakeholder face-to-face workshop. RESULTS: Thirty-five experts and 84 members of the public took part in the surveys, with 164 patients and clinicians attending the final workshop. There was substantial agreement on the need for a targeted screening pathway that would employ a combined approach (imaging + genetic testing). The target population would include the first- and second-degree adult (> 15 years) relatives, with no upper age limit of affected patients. Disagreement persisted about the screening process, sequence, personnel, the imaging method to adopt, computed tomography (CT) scan vs magnetic resonance imaging (MRI), and the specifics of a potential trial, including willingness to undergo randomisation, and measures of effectiveness and acceptability. CONCLUSION: A Delphi process, initiated by patients, identified areas of uncertainty with respect to behaviour, process, and the design of a targeted screening programme for thoracic aortic disease that requires further research prior to any future trial.
No takes yet. Share an insight, caveat, or question.
Abbasciano et al. (2020) studied Thoracic aortic disease (n=164). Delphi consensus process was evaluated on Consensus on the acceptability of screening, optimal sequence and choice of tests, long-term patient management, and choice of trial design. A Delphi process identified substantial agreement on the need for a targeted screening pathway using combined imaging and genetic testing for adult relatives of patients with thoracic aortic disease.
Synapse has enriched 10 related papers. Consider them for comparative context: